This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.
The report explores future marketing and technological trends in the Europe; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,
Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s),
Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin,
Full Crossmatch), Rh (D, Du).
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc,
HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.
Sales and Market Share Analysis
Sales and market share estimates for leading suppliers
of transfusion diagnostic products by country and individual product.
France, Germany, Italy, Spain, UK
Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new products in R&D.
Market Segmentation Analysis
- Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth,
and key suppliers, by country.
- Test volume and sales forecasts for over 40 blood typing,
grouping and infectious disease screening tests,
including NAT, by country and market segment:
- Blood Centers
- Commercial/Private Laboratories
Current and Emerging Products
- Analysis of current and emerging blood typing,
grouping and infectious disease screening tests.
- Review of automated and semi-automated
- Assessment of current and emerging
technologies, and their potential applications
for the transfusion diagnostics market.
- Comprehensive lists of companies developing
or marketing new technologies and products, by test.
- New product development opportunities
with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Contains 600 pages and 170 tables
SIMILAR MARKET STUDIES
2014 Analysis of the Japanese Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices-Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
February 2014 | $2500 | View Details >>
This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by product and country for Gen-Probe/Hologic and its main competitors, as well as a profile of the company’s diagnostics business. List of Tables Infectious Disease Testing ...
September 2015 | $2450 | View Details >>
This DataPack contains tables from VPGMarketResearch.com new report, 2016 Emerging Opportunities in the Respiratory Syncytial Virus Diagnostic Testing Market. For pricing information on DataPack sections or individual tables, please contact Customer Service.
January 2016 | $0 | View Details >>
This 145-page report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry chemistry, biosensors, robotics, molecular diagnostics and others.The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 145 pages
September 2015 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research